PNC Financial Services Group
PYXS icon

PNC Financial Services Group’s Pyxis Oncology PYXS Stock Holding History

PNC Financial Services Group’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.49K Buy
+6,500
New +$9.8K ﹤0.01% 3976
2023
Q3 		– Sell
-100
Closed -$256 – 4718
2023
Q2 		$256 Hold
100
– – ﹤0.01% 4646
2023
Q1 		$401 Buy
+100
New +$200 ﹤0.01% 4546

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's PYXS Position: Q1 2026 in Review

PNC Financial Services Group opened a new position in Pyxis Oncology (PYXS) in Q1 2026: 6,500 shares worth $9.49K. The stake represents ﹤0.01% of the portfolio and ranks #3976 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in PYXS as recently as Q2 2023.

PNC Financial Services Group first reported a position in PYXS in Q1 2023 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • PNC Financial Services Group held 6,500 shares of Pyxis Oncology worth $9.49K as of Q1 2026.
  • Pyxis Oncology was a new PNC Financial Services Group position in Q1 2026.
  • Pyxis Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3976 holding.
  • PNC Financial Services Group first reported a position in Pyxis Oncology in Q1 2023 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.